Nasdaq:US$13.33 (-0.09) | HKEX:HK$20.30 (-0.52) | AIM:£1.95 (-0.06)
News & Presentations
Previous Article   |   Next Article
Presentations, Scientific Publications | 27 Sep 2015

ESMO 2015: Phase II trial of fruquintinib in metastatic colorectal cancer

1 items
View PDF